LakeShore Biopharma Schedules Crucial EGM
Company Announcements

LakeShore Biopharma Schedules Crucial EGM

LakeShore Biopharma (LSB) has released an update.

LakeShore Biopharma has announced an Extraordinary General Meeting (EGM) to be held virtually on July 25, 2024, in response to a requisition by shareholders holding over 10% of the company’s votes. The meeting aims to address key issues such as the rationale behind recent director resignations, the establishment of new subsidiaries, and the impact of ongoing arbitration proceedings on the company’s financial stability. Shareholders registered by July 15 will be eligible to vote at the EGM.

For further insights into LSB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Advances PIKA Rabies Vaccine Approval
TheFlyLakeShore Biopharma initiates BLA submission to DRAP for PIKA rabies vaccine
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Announces Leadership Transition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App